Back to Search Start Over

Minimal residual disease (MRD) assessment by flow cytometry after ASCT for AL amyloidosis: are we there yet?

Authors :
Lee H
Duggan P
Neri P
Tay J
Bahlis NJ
Jimenez-Zepeda VH
Source :
Bone marrow transplantation [Bone Marrow Transplant] 2017 Jun; Vol. 52 (6), pp. 915-917. Date of Electronic Publication: 2017 Mar 13.
Publication Year :
2017

Details

Language :
English
ISSN :
1476-5365
Volume :
52
Issue :
6
Database :
MEDLINE
Journal :
Bone marrow transplantation
Publication Type :
Academic Journal
Accession number :
28287637
Full Text :
https://doi.org/10.1038/bmt.2017.28